A wearable ultrasound scanner could detect breast cancer earlier
A wearable ultrasound scanner could detect breast cancer earlier MIT News
Improving Breast Cancer Survival Rates with Wearable Ultrasound Device
When breast cancer is diagnosed in the earliest stages, the survival rate is nearly 100 percent. However, for tumors detected in later stages, that rate drops to around 25 percent.
The Importance of Early Detection
In hopes of improving the overall survival rate for breast cancer patients, MIT researchers have designed a wearable ultrasound device that could allow people to detect tumors when they are still in early stages. In particular, it could be valuable for patients at high risk of developing breast cancer in between routine mammograms.
How the Wearable Ultrasound Device Works
The device is a flexible patch that can be attached to a bra, allowing the wearer to move an ultrasound tracker along the patch and image the breast tissue from different angles. In the new study, the researchers showed that they could obtain ultrasound images with resolution comparable to that of the ultrasound probes used in medical imaging centers.
MIT graduate student Wenya Du, Research Scientist Lin Zhang, Emma Suh ’23, and Dabin Lin, a professor at Xi’an Technological University, are the lead authors of the paper, which appears today in Science Advances.
The Goal of Increasing Survival Rates
For this project, the researchers aimed to increase the survival rate of breast cancer patients by targeting those who are most likely to develop interval cancer. Breast tumors that develop in between regularly scheduled mammograms account for 20 to 30 percent of all breast cancer cases and tend to be more aggressive than those found during routine scans. With more frequent screening using the wearable ultrasound device, the researchers hope to increase the survival rate to up to 98 percent.
A Promising Diagnostic Tool
To make their vision of a diagnostic bra a reality, the researchers designed a miniaturized ultrasound scanner that could be incorporated into a bra and allow for more frequent screening. The scanner is based on the same kind of ultrasound technology used in medical imaging centers but incorporates a novel piezoelectric material that allowed for miniaturization. The device is wearable and easy to use, providing real-time, user-friendly monitoring of breast tissue.
The wearable ultrasound patch can be used over and over, making it suitable for home use by people at high risk for breast cancer or those who don’t have regular access to screening. The researchers envision that it could eliminate the need for women to travel to an imaging center, making early detection more accessible and convenient.
Advancements in Ultrasound Research and Medical Device Designs
The development of this wearable ultrasound device significantly advances ultrasound research and medical device designs. It leverages advances in materials, low-power circuits, AI algorithms, and biomedical systems. The researchers also plan to explore adapting the ultrasound technology to scan other parts of the body.
Conclusion
The wearable ultrasound device offers a fundamental capability in the detection and early diagnosis of breast cancer, which is key to a positive outcome. With its potential to increase survival rates and provide a more reliable, comfortable, and less intimidating diagnostic tool, this technology aligns with the Sustainable Development Goals (SDGs) of ensuring good health and well-being (SDG 3) and promoting gender equality (SDG 5).
SDGs, Targets, and Indicators Analysis:
1. Which SDGs are addressed or connected to the issues highlighted in the article?
- SDG 3: Good Health and Well-being
- SDG 5: Gender Equality
The article discusses the development of a wearable ultrasound device that aims to improve the overall survival rate for breast cancer patients. This aligns with SDG 3, which focuses on ensuring healthy lives and promoting well-being for all at all ages. Additionally, the article mentions that the device can be attached to a bra, highlighting the potential impact on women’s health and gender equality, which is addressed in SDG 5.
2. What specific targets under those SDGs can be identified based on the article’s content?
- Target 3.4: By 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
- Target 5.6: Ensure universal access to sexual and reproductive health and reproductive rights as agreed in accordance with the Programme of Action of the International Conference on Population and Development and the Beijing Platform for Action and the outcome documents of their review conferences.
The article’s content aligns with Target 3.4 of SDG 3, as it aims to improve early detection of breast cancer, which can lead to a reduction in premature mortality from this non-communicable disease. Additionally, Target 5.6 of SDG 5 is relevant as the wearable ultrasound device can provide universal access to breast cancer screening, contributing to women’s reproductive health and rights.
3. Are there any indicators mentioned or implied in the article that can be used to measure progress towards the identified targets?
- Indicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes, or chronic respiratory disease.
- Indicator 5.6.1: Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use, and reproductive health care.
The article does not explicitly mention specific indicators. However, progress towards Target 3.4 of SDG 3 can be measured using Indicator 3.4.1, which tracks the mortality rate attributed to cancer. Progress towards Target 5.6 of SDG 5 can be measured using Indicator 5.6.1, which assesses the proportion of women who make their own informed decisions regarding reproductive health care.
SDGs, Targets, and Indicators Table:
SDGs | Targets | Indicators |
---|---|---|
SDG 3: Good Health and Well-being | Target 3.4: By 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being. | Indicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes, or chronic respiratory disease. |
SDG 5: Gender Equality | Target 5.6: Ensure universal access to sexual and reproductive health and reproductive rights as agreed in accordance with the Programme of Action of the International Conference on Population and Development and the Beijing Platform for Action and the outcome documents of their review conferences. | Indicator 5.6.1: Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use, and reproductive health care. |
Behold! This splendid article springs forth from the wellspring of knowledge, shaped by a wondrous proprietary AI technology that delved into a vast ocean of data, illuminating the path towards the Sustainable Development Goals. Remember that all rights are reserved by SDG Investors LLC, empowering us to champion progress together.
Source: news.mit.edu
Join us, as fellow seekers of change, on a transformative journey at https://sdgtalks.ai/welcome, where you can become a member and actively contribute to shaping a brighter future.